{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:38:09Z","timestamp":1760143089739,"version":"build-2065373602"},"reference-count":119,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia, Portugal","doi-asserted-by":"publisher","award":["SFRH\/BD\/147629\/2019","UIDB\/00006\/2020"],"award-info":[{"award-number":["SFRH\/BD\/147629\/2019","UIDB\/00006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The diagnosis and pathology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) remain under debate. However, there is a growing body of evidence for an autoimmune component in ME\/CFS caused by the Epstein-Barr virus (EBV) and other viral infections. Materials and Methods: In this work, we analyzed a large public dataset on the IgG antibodies to 3054 EBV peptides to understand whether these immune responses could help diagnose patients and trigger pathological autoimmunity; we used healthy controls (HCs) as a comparator cohort. Subsequently, we aimed at predicting the disease status of the study participants using a super learner algorithm targeting an accuracy of 85% when splitting data into train and test datasets. Results: When we compared the data of all ME\/CFS patients or the data of a subgroup of those patients with non-infectious or unknown disease triggers to the data of the HC, we could not find an antibody-based classifier that would meet the desired accuracy in the test dataset. However, we could identify a 26-antibody classifier that could distinguish ME\/CFS patients with an infectious disease trigger from the HCs with 100% and 90% accuracies in the train and test sets, respectively. We finally performed a bioinformatic analysis of the EBV peptides associated with these 26 antibodies. We found no correlation between the importance metric of the selected antibodies in the classifier and the maximal sequence homology between human proteins and each EBV peptide recognized by these antibodies. Conclusions: In conclusion, these 26 antibodies against EBV have an effective potential for disease diagnosis in a subset of patients. However, the peptides associated with these antibodies are less likely to induce autoimmune B-cell responses that could explain the pathogenesis of ME\/CFS.<\/jats:p>","DOI":"10.3390\/medicina60010161","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T11:15:01Z","timestamp":1705317301000},"page":"161","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-0354","authenticated-orcid":false,"given":"Andr\u00e9","family":"Fonseca","sequence":"first","affiliation":[{"name":"Faculty of Sciences and Technology, University of Algarve, 8005-139 Faro, Portugal"},{"name":"CEAUL\u2014Centre of Statistics and its Applications, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal"}]},{"given":"Mateusz","family":"Szysz","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics & Information Science, Warsaw University of Technology, 00-662 Warsaw, Poland"}]},{"given":"Hoang Thien","family":"Ly","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics & Information Science, Warsaw University of Technology, 00-662 Warsaw, Poland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-6078","authenticated-orcid":false,"given":"Clara","family":"Cordeiro","sequence":"additional","affiliation":[{"name":"Faculty of Sciences and Technology, University of Algarve, 8005-139 Faro, Portugal"},{"name":"CEAUL\u2014Centre of Statistics and its Applications, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-1706","authenticated-orcid":false,"given":"Nuno","family":"Sep\u00falveda","sequence":"additional","affiliation":[{"name":"CEAUL\u2014Centre of Statistics and its Applications, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal"},{"name":"Faculty of Mathematics & Information Science, Warsaw University of Technology, 00-662 Warsaw, Poland"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rivera, M.C., Mastronardi, C., Silva-Aldana, C.T., Arcos-Burgos, M., and Lidbury, B.A. (2019). Myalgic encephalomyelitis\/chronic fatigue syndrome: A comprehensive review. Diagnostics, 9.","DOI":"10.3390\/diagnostics9030091"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Deumer, U.S., Varesi, A., Floris, V., Savioli, G., Mantovani, E., Lopez-Carrasco, P., Rosati, G.M., Prasad, S., and Ricevuti, G. (2021). Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): An Overview. J. Clin. Med., 10.","DOI":"10.3390\/jcm10204786"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e150377","DOI":"10.1172\/JCI150377","article-title":"Pathomechanisms and possible interventions in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"131","author":"Fluge","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"628029","DOI":"10.3389\/fmed.2021.628029","article-title":"Hypothesis: Mechanisms that Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"8","author":"Stanculescu","year":"2021","journal-title":"Front. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"789784","DOI":"10.3389\/fneur.2021.789784","article-title":"Lessons from Heat Stroke for Understanding Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"12","author":"Stanculescu","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fneur.2020.00826","article-title":"How Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) Progresses: The Natural History of ME\/CFS","volume":"11","author":"Nacul","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2018.00229","article-title":"Infection elicited autoimmunity and Myalgic encephalomyelitis\/chronic fatigue syndrome: An explanatory model","volume":"9","author":"Blomberg","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome\u2013Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12035-013-8553-0","article-title":"The emerging role of autoimmunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/cfs)","volume":"49","author":"Morris","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"668944","DOI":"10.3389\/fmed.2021.668944","article-title":"Adolescent and Young Adult ME\/CFS After Confirmed or Probable COVID-19","volume":"8","author":"Petracek","year":"2021","journal-title":"Front. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jason, L.A., and Dorri, J.A. (2022). ME\/CFS and Post-Exertional Malaise among Patients with Long COVID. Neurol. Int., 15.","DOI":"10.3390\/neurolint15010001"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19907","DOI":"10.1038\/s41598-023-47218-1","article-title":"Functionality, physical activity, fatigue and quality of life in patients with acute COVID-19 and Long COVID infection","volume":"13","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"656797","DOI":"10.3389\/fimmu.2021.656797","article-title":"Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome","volume":"12","author":"Paiva","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ariza, M.E. (2021). Myalgic encephalomyelitis\/chronic fatigue syndrome: The human herpesviruses are back!. Biomolecules, 11.","DOI":"10.3389\/fimmu.2020.01400"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3389\/fimmu.2019.02684","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory T Cells and Chronic Human Herpesvirus Infections","volume":"10","author":"Carneiro","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12967-023-04515-7","article-title":"Epstein\u2013Barr virus-acquired immunodeficiency in myalgic encephalomyelitis\u2014Is it present in long COVID?","volume":"21","author":"Paiva","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e158193","DOI":"10.1172\/jci.insight.158193","article-title":"EBV\/HHV-6A dUTPases contribute to myalgic encephalomyelitis\/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities","volume":"7","author":"Cox","year":"2022","journal-title":"JCI Insight"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/2049-632X.12066","article-title":"Peptide matching between Epstein-Barr virus and human proteins","volume":"69","author":"Capone","year":"2013","journal-title":"Pathog. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/ard.50.11.772","article-title":"Cross reaction of antibodies to a glycine\/alanine repeat sequence of Epstein-Barr virus nuclear antigen-i with collagen, cytokeratin, and actin","volume":"50","author":"Baboonian","year":"1991","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3389\/fimmu.2019.01946","article-title":"Antibodies to human herpesviruses in myalgic encephalomyelitis\/chronic fatigue syndrome patients","volume":"10","author":"Blomberg","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lerner, A.M., Ariza, M.E., Williams, M., Jason, L., Beqaj, S., Fitzgerald, J.T., Lemeshow, S., and Glaser, R. (2012). Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047891"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fped.2019.00059","article-title":"Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"7","author":"Kerr","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"686736","DOI":"10.3389\/fmed.2021.686736","article-title":"Herpesviruses Serology Distinguishes Different Subgroups of Patients from the United Kingdom Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Biobank","volume":"8","author":"Domingues","year":"2021","journal-title":"Front. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Malato, J., Gra\u00e7a, L., and Sep\u00falveda, N. (2023). Impact of Misdiagnosis in Case-Control Studies of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030531"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1177\/1359105317695803","article-title":"How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis\/chronic fatigue syndrome studies?","volume":"24","author":"Nacul","year":"2019","journal-title":"J. Health Psychol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3389\/fimmu.2020.01400","article-title":"Commentary: Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Patients","volume":"11","author":"Ariza","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Loebel, M., Eckey, M., Sotzny, F., Hahn, E., Bauer, S., Grabowski, P., Zerweck, J., Holenya, P., Hanitsch, L.G., and Wittke, K. (2017). Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179124"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"921101","DOI":"10.3389\/fmed.2022.921101","article-title":"Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis","volume":"9","author":"Malato","year":"2022","journal-title":"Front. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/sam.11583","article-title":"Optimal ratio for data splitting","volume":"15","author":"Roshan","year":"2022","journal-title":"Stat. Anal. Data Min. ASA Data Sci. J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Van Der Laan, M.J., Polley, E.C., and Hubbard, A.E. (2007). Super learner. Stat. Appl. Genet. Mol. Biol., 6.","DOI":"10.2202\/1544-6115.1309"},{"key":"ref_32","first-page":"1","article-title":"Optimalcutpoints: An R package for selecting optimal cutpoints in diagnostic tests","volume":"61","year":"2014","journal-title":"J. Stat. Softw."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Valletta, J.J., and Recker, M. (2017). Identification of immune signatures predictive of clinical protection from malaria. PLoS Comput. Biol., 13.","DOI":"10.1371\/journal.pcbi.1005812"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1038\/s41467-019-12552-4","article-title":"The Eighty Five Percent Rule for optimal learning","volume":"10","author":"Wilson","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: Current status, taxonomic expansion, and functional annotation","volume":"44","author":"Wright","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1073\/pnas.90.12.5873","article-title":"Applications and statistics for multiple high-scoring segments in molecular sequences","volume":"90","author":"Karlin","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Softw."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.C., and M\u00fcller, M. (2011). pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-77"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v077.i01","article-title":"ranger: A Fast Implementation of Random Forests for High Dimensional Data in C++ and R","volume":"77","author":"Wright","year":"2017","journal-title":"J. Stat. Softw."},{"key":"ref_40","unstructured":"Polley, E., LeDell, E., Kennedy, C., and van der Laan, M. (2023, November 21). SuperLearner: Super. Learner Prediction 2021. R Package Version 2.0-28. Available online: https:\/\/cran.r-project.org\/package=SuperLearner."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1073\/pnas.1902623116","article-title":"Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk","volume":"116","author":"Tengvall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2021.07.007","article-title":"Impact of genetic variation on the molecular mimicry between Anoctamin-2 and Epstein-Barr virus nuclear antigen 1 in Multiple Sclerosis","volume":"238","year":"2021","journal-title":"Immunol. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"O\u2019Neal, A.J., Glass, K.A., Emig, C.J., Vitug, A.A., Henry, S.J., Shungu, D.C., Mao, X., Levine, S.M., and Hanson, M.R. (2022). Survey of Anti-Pathogen Antibody Levels in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Proteomes, 10.","DOI":"10.3390\/proteomes10020021"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11065-005-3588-2","article-title":"Chronic fatigue syndrome: The need for subtypes","volume":"15","author":"Jason","year":"2005","journal-title":"Neuropsychol. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.04.005","article-title":"Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1","volume":"272","author":"Ruprecht","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jason, L., Ohanian, D., Brown, A., Sunnquist, M., McManimen, S., Klebek, L., Fox, P., and Sorenson, M. (2017). Differentiating Multiple Sclerosis from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. Insights Biomed., 2.","DOI":"10.21767\/2572-5610.10027"},{"key":"ref_48","first-page":"41","article-title":"Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis","volume":"4","author":"Ohanian","year":"2016","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E18250","DOI":"10.1016\/j.heliyon.2023.e18250","article-title":"Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and multiple sclerosis","volume":"9","author":"Domingues","year":"2023","journal-title":"Heliyon"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"103452","DOI":"10.1016\/j.autrev.2023.103452","article-title":"Understanding, diagnosing, and treating Myalgic encephalomyelitis\/chronic fatigue syndrome-State of the art: Report of the 2nd international meeting at the Charit\u00e9 Fatigue Center","volume":"22","author":"Steiner","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Scheibenbogen, C., Loebel, M., Freitag, H., Krueger, A., Bauer, S., Antelmann, M., Doehner, W., Scherbakov, N., Heidecke, H., and Reinke, P. (2018). Immunoadsorption to remove \u00df2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS\/ME. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193672"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"T\u00f6lle, M., Freitag, H., Antelmann, M., Hartwig, J., Schuchardt, M., van der Giet, M., Eckardt, K.U., Grabowski, P., and Scheibenbogen, C. (2020). Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082443"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Stein, E., Heindrich, C., Wittke, K., Kedor, C., Kim, L., Freitag, H., Kr\u00fcger, A., T\u00f6lle, M., and Scheibenbogen, C. (2023). Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME\/CFS Patients with Elevated \u00df2-Adrenergic Receptor Autoantibodies\u2014An Interim Report. J. Clin. Med., 12.","DOI":"10.1101\/2023.08.31.23294813"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Fluge, \u00d8., Risa, K., Lunde, S., Alme, K., Rekeland, I.G., Sapkota, D., Kristoffersen, E.K., S\u00f8rland, K., Bruland, O., and Dahl, O. (2015). B-Lymphocyte Depletion in Myalgic Encephalopathy\/Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129898"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Fluge, \u00d8., Bruland, O., Risa, K., Storstein, A., Kristoffersen, E.K., Sapkota, D., N\u00e6ss, H., Dahl, O., Nyland, H., and Mella, O. (2011). Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026358"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M18-1451","article-title":"B-Lymphocyte Depletion in Patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"170","author":"Fluge","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fmed.2020.00162","article-title":"Intravenous Cyclophosphamide in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. An Open-Label Phase II Study","volume":"7","author":"Rekeland","year":"2020","journal-title":"Front. Med."},{"key":"ref_58","first-page":"14","article-title":"Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis","volume":"2011","author":"Patti","year":"2011","journal-title":"Autoimmune Dis."},{"key":"ref_59","first-page":"267","article-title":"The influence of cyclophosphamide on antibody formation in the mouse","volume":"126","author":"Willers","year":"1975","journal-title":"Ann. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: Implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780180113","article-title":"The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases","volume":"18","author":"Hurd","year":"1975","journal-title":"Arthritis Rheum."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Nacul, L.C., Lacerda, E.M., Pheby, D., Campion, P., Molokhia, M., Fayyaz, S., Leite, J.C., Poland, F., Howe, A., and Drachler, M.L. (2011). Prevalence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) in three regions of England: A repeated cross-sectional study in primary care. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-91"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fped.2019.00012","article-title":"Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Chu","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41591-020-0841-4","article-title":"Development and validation of serological markers for detecting recent Plasmodium vivax infection","volume":"26","author":"Longley","year":"2020","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","article-title":"Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities","volume":"112","author":"Helb","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: A user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e144201","DOI":"10.1172\/JCI144201","article-title":"Passive transfer of fibromyalgia symptoms from patients to mice","volume":"131","author":"Goebel","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpain.2022.03.045","article-title":"Development of a Mouse Model for Chronic Fatigue Syndrome","volume":"23","author":"Janowski","year":"2022","journal-title":"J. Pain."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"890217","DOI":"10.3389\/fneur.2022.890217","article-title":"Animal Models for Neuroinflammation and Potential Treatment Methods","volume":"13","author":"Tamura","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bastiaan Holwerda, S.J., and de Laat, W. (2013). CTCF: The protein, the binding partners, the binding sites and their chromatin loops. Philos. Trans. R. Soc. B Biol. Sci., 368.","DOI":"10.1098\/rstb.2012.0369"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e55146","DOI":"10.15252\/embr.202255146","article-title":"CTCF shapes chromatin structure and gene expression in health and disease","volume":"23","author":"Dehingia","year":"2022","journal-title":"EMBO Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1126\/sciimmunol.aat5861","article-title":"Molecular diversification of regulatory T cells in nonlymphoid tissues","volume":"3","author":"DiSpirito","year":"2018","journal-title":"Sci. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"840002","DOI":"10.3389\/fimmu.2022.840002","article-title":"Cohesin-Mediated Chromatin Interactions and Autoimmunity","volume":"13","author":"Chandrasekaran","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11926-008-0079-5","article-title":"Gene profiling of patients with chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"10","author":"Kerr","year":"2008","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/jcp.2005.025718","article-title":"Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome","volume":"58","author":"Kaushik","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2058738418820402","DOI":"10.1177\/2058738418820402","article-title":"Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"33","author":"Sweetman","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clinthera.2019.02.012","article-title":"Epigenetic Components of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation","volume":"41","author":"Ovejero","year":"2019","journal-title":"Clin. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"De Vega, W.C., Herrera, S., Vernon, S.D., and McGowan, P.O. (2017). Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). BMC Med. Genom., 10.","DOI":"10.1186\/s12920-017-0248-3"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2008.08.003","article-title":"Immunological aspects of chronic fatigue syndrome","volume":"8","author":"Lorusso","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8097872","DOI":"10.1155\/2020\/8097872","article-title":"AEBP1 is a Novel Oncogene: Mechanisms of Action and Signaling Pathways","volume":"2020","author":"Majdalawieh","year":"2020","journal-title":"J. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1148224","DOI":"10.3389\/fgene.2023.1148224","article-title":"Case report: Two individuals with AEBP1-related classical-like EDS: Further clinical characterisation and description of novel AEBP1 variants","volume":"14","author":"Angwin","year":"2023","journal-title":"Front. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ritelli, M., Cinquina, V., Venturini, M., Pezzaioli, L., Formenti, A.M., Chiarelli, N., and Colombi, M. (2019). Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome. Genes, 10.","DOI":"10.3390\/genes10020135"},{"key":"ref_83","first-page":"597","article-title":"Chronic fatigue syndrome is commonly diagnosed in patients with Ehlers-Danlos syndrome hypermobility type\/joint hypermobility syndrome","volume":"29","author":"Castori","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.31542","article-title":"Chronic fatigue in Ehlers-Danlos syndrome-Hypermobile type","volume":"175","author":"Hakim","year":"2017","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Nacul, L., Authier, F.J., Scheibenbogen, C., Lorusso, L., Helland, I.B., Martin, J.A., Sirbu, C.A., Mengshoel, A.M., Polo, O., and Behrends, U. (2021). European Network on Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME\/CFS in Europe. Medicina, 57.","DOI":"10.3390\/medicina57050510"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1038\/tp.2015.208","article-title":"Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"6","author":"Schlauch","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1093\/hmg\/ddaa169","article-title":"Genetic risk factors of ME\/CFS: A critical review","volume":"29","author":"Dibble","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/15592294.2018.1549769","article-title":"Genome-epigenome interactions associated with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"13","author":"Herrera","year":"2018","journal-title":"Epigenetics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbi.2022.03.010","article-title":"Genetic association study in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) identifies several potential risk loci","volume":"102","author":"Hajdarevic","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Das, S., Taylor, K., Kozubek, J., Sardell, J., and Gardner, S. (2022). Genetic risk factors for ME\/CFS identified using combinatorial analysis. J. Transl. Med., 20.","DOI":"10.1186\/s12967-022-03815-8"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12967-022-03346-2","article-title":"Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME\/CFS)","volume":"20","author":"Haffke","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/ehf2.12633","article-title":"Peripheral endothelial dysfunction in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Scherbakov","year":"2020","journal-title":"ESC Hear. Fail."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1038\/s41598-021-89834-9","article-title":"Altered endothelial dysfunction-related miRs in plasma from ME\/CFS patients","volume":"11","author":"Blauensteiner","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fimmu.2012.00287","article-title":"The danger theory: 20 years later","volume":"3","author":"Pradeu","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","article-title":"Danger signals: SOS to the immune system","volume":"13","author":"Gallucci","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0167-5699(91)90093-9","article-title":"Autoimmunity, microbial immunity and the immunological homunculus","volume":"12","author":"Cohen","year":"1991","journal-title":"Immunol. Today"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Quintana, F.J., Mimran, A., Carmi, P., Mor, F., and Cohen, I.R. (2008). HSP60 as a target of anti-ergotypic regulatory T cells. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0004026"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2796.2011.02488.x","article-title":"Chronic fatigue syndrome: Acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant\/antioxidant status and heat shock proteins","volume":"272","author":"Jammes","year":"2012","journal-title":"J. Intern. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.25011\/cim.v31i6.4917","article-title":"Differential heat shock protein responses to strenuous standardized exercise in chronic fatigue syndrome patients and matched healthy controls","volume":"31","author":"Thambirajah","year":"2008","journal-title":"Clin. Investig. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2015.1346","article-title":"Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: An IOM Report on Redefining an Illness","volume":"313","author":"Clayton","year":"2015","journal-title":"JAMA"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Elfaitouri, A., Herrmann, B., B\u00f6lin-Wiener, A., Wang, Y., Gottfries, C.G., Zachrisson, O., Pipkorn, R., R\u00f6nnblom, L., and Blomberg, J. (2013). Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081155"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.4049\/jimmunol.163.6.3071","article-title":"Vasoactive Intestinal Peptide Synergizes with TNF-\u03b1 in Inducing Human Dendritic Cell Maturation","volume":"163","author":"Delneste","year":"1999","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1317.031","article-title":"VIP-PACAP system in immunity: New insights for multitarget therapy","volume":"1070","author":"Gomariz","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mehy.2004.01.012","article-title":"Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?","volume":"62","author":"Staines","year":"2004","journal-title":"Med. Hypotheses"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J. Transl. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmed.2007.04.003","article-title":"Vasoactive intestinal peptide and regulatory T-cell induction: A new mechanism and therapeutic potential for immune homeostasis","volume":"13","author":"Delgado","year":"2007","journal-title":"Trends Mol. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbi.2015.07.004","article-title":"Chronic fatigue syndrome and circulating cytokines: A systematic review","volume":"50","author":"Blundell","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"ref_109","first-page":"179","article-title":"A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFN\u03b3874 rare alleles","volume":"24","author":"Badulli","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2020.00578","article-title":"Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated with ME\/CFS with Infectious Onset","volume":"11","author":"Steiner","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"101441","DOI":"10.1016\/j.isci.2020.101441","article-title":"Residue-Specific Message Encoding in CD40-Ligand","volume":"23","author":"Sarode","year":"2020","journal-title":"IScience"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4049\/jimmunol.173.2.1292","article-title":"Differential induction of IL-1beta and TNF by CD40 ligand or cellular contact with stimulated T cells depends on the maturation stage of human monocytes","volume":"173","author":"Burger","year":"2004","journal-title":"J. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.4049\/jimmunol.171.12.6750","article-title":"CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism","volume":"171","author":"Andrade","year":"2003","journal-title":"J. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"45414","DOI":"10.1074\/jbc.M309601200","article-title":"CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site","volume":"278","author":"Lu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.4049\/jimmunol.176.4.2617","article-title":"TNF-\u03b1 Blockade Down-Regulates the CD40\/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn\u2019s Disease","volume":"176","author":"Danese","year":"2006","journal-title":"J. Immunol."},{"key":"ref_116","first-page":"615","article-title":"Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome","volume":"47","author":"White","year":"2010","journal-title":"Psychophysiology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e1400121","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci. Adv."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4049\/jimmunol.168.2.713","article-title":"IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): A mechanism for T cell-independent DC activation","volume":"168","author":"Luft","year":"2002","journal-title":"J. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wesa, A., and Galy, A. (2002). Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol., 3.","DOI":"10.1186\/1471-2172-3-14"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/1\/161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:47:21Z","timestamp":1760104041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/1\/161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["medicina60010161"],"URL":"https:\/\/doi.org\/10.3390\/medicina60010161","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,1,15]]}}}